Profile
DHR-PB TMO DHR IQV A IDXX
Company Name Danaher Corporation Thermo Fisher Scientific Inc. Danaher Corporation IQVIA Holdings Inc. Agilent Technologies, Inc. IDEXX Laboratories, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research
Market Cap $916.76B $231.76B $197.82B $43.69B $40.06B $38.79B
Employees 79.00K 122.00K 61.00K 88.00K 17.60K 11.00K
CEO Mr. Rainer M. Blair Mr. Marc N. Casper Mr. Rainer M. Blair Mr. Ari Bousbib Mr. Padraig McDonnell Mr. Jonathan J. Mazelsky
Ratings
DHR-PB TMO DHR IQV A IDXX
Quant Rating Score 5 3 3 3 3 3
Quant Rating Strong Buy Neutral Neutral Neutral Neutral Neutral
Trading
DHR-PB TMO DHR IQV A IDXX
Last Close $1261.26 $607.14 $273.91 $239.67 $137.32 $469.71
High 52 $1261.26 $607.14 $273.91 $259.1 $154.64 $576.87
Low 52 $1261.26 $431.41 $185.1 $177.16 $101.17 $391.37
Price vs. 52 Week High 0 % 0 % 0 % -7.5 % -11.2 % -18.58 %
Price vs. 52 Week Low 0 % 40.73 % 47.98 % 35.28 % 35.73 % 20.02 %
Total Return
DHR-PB TMO DHR IQV A IDXX
1 Month Return 0 % 10.23 % 8.8 % 12.65 % 4.98 % -4.91 %
3 Month Return 0 % 5.85 % 11.08 % 2.04 % -0.3 % -5.93 %
6 Month Return 0 % 10.93 % 17.56 % 10.91 % 4.83 % -10.53 %
9 Month Return 0 % 40.73 % 45.79 % 33.19 % 33.62 % 20.02 %
YTD Return 0 % 14.38 % 18.4 % 3.58 % -1.23 % -15.38 %
1 Year Return 0 % 8.41 % 7.3 % 6.73 % 8.42 % -13.97 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
DHR-PB TMO DHR IQV A IDXX
Dividend Yield Percentage (TTM) 0.38 % 0.24 % 0.38 % - 0.68 % -
Dividend Paid and Capex Coverage Ration (TTM) 3.16 % 4.82 % 2.53 % 3.98 % 3.02 % 7.41 %
Dividend Per Share (TTM) 1.05 % 1.48 % 1.05 % - 0.93 % -
Payout Ratio (TTM) 17.87 % 8.91 % 28.62 % - 21.74 % -
Growth
DHR-PB TMO DHR IQV A IDXX
Asset Growth 0.16 % 1.62 % 0.16 % 5.3 % 2.35 % 18.68 %
Gross Profit Growth -25.94 % -21.93 % -25.94 % -17.76 % -6.9 % 9.26 %
Revenue Growth -24.09 % -4.58 % -24.09 % 4.13 % -0.22 % 8.72 %
Revenue 3 Year 2.8 % 36.47 % 2.8 % 37.49 % 34.51 % 38.96 %
Revenue 5 Year 14.24 % 83.24 % 14.24 % 59.72 % 51.82 % 72.97 %
Revenue 10 Year 18.09 % 205.6 % 18.09 % 98.74 % 16.86 % 240.27 %
EBIT Growth -40.12 % -12.81 % -40.12 % 15.73 % -16.56 % 22.07 %
Net Income Growth -33.92 % -13.74 % -33.92 % 24.47 % -1.12 % 24.44 %
Net Income 3 Yeari Growth Per Share 25.29 % -3.52 % 25.29 % 406.6 % 81.26 % 49.23 %
Net Income 5 Yeari Growth Per Share 70.95 % 112.51 % 70.95 % 481.09 % 328.44 % 134.38 %
Net Income 10 Yeari Growth Per Share 67.05 % 339.48 % 67.05 % 304.81 % 98.65 % 475.93 %
Operating Income Growth -40.12 % -12.81 % -40.12 % 15.73 % -16.56 % 22.07 %
Operating Cash Flow Growth (CFG) -15.91 % -8.17 % -15.91 % -4.91 % 35.06 % 66.95 %
Operating 3 Year CFG 10.65 % 4.04 % 10.65 % 14.18 % 102.22 % 43.71 %
Operating 5 Year CFG 69.44 % 92.7 % 69.44 % 89.93 % 77.99 % 136.94 %
Operating 10 Year CFG 88.83 % 290.23 % 88.83 % 265.29 % 78.41 % 371.66 %
EPS Growth -34.29 % -12.41 % -34.29 % 26.98 % 0.72 % 25.25 %
EPS Diluted Growth -33.82 % -12.41 % -33.82 % 27.45 % 0.24 % 25.28 %
Book Value Per Share 5.14 % 7.9 % 5.14 % 8.21 % 12.39 % 145.51 %
Share Holder 3 Year Equity Growth Per Share 28.97 % 38.91 % 28.97 % 6.01 % 26.07 % 141.3 %
Share Holder 5 Year Equity Growth Per Share 80.33 % 76.4 % 80.33 % 0.89 % 39.74 % 16418.79 %
Share Holder 10 Year Equity Growth Per Share 125.79 % 158.74 % 125.79 % 718.56 % 28.25 % 266.68 %
Dividend Per Share Growth 50.21 % 16.73 % 50.21 % - 7.8 % -
Dividend 3 Year Growth Per Share 94.58 % 59.21 % 94.58 % - 25.46 % -
Dividend 5 Year Growth Per Share 173.92 % 104.77 % 173.92 % - 51.49 % -
Dividend 10 Year Growth Per Share 2163.67 % 125.8 % 2163.67 % - 97.03 % -
Debt Growth -0.72 % 1.24 % -0.72 % 9.38 % -1.23 % -29.7 %
Free Cash Flow Growth -21.53 % 0.23 % -21.53 % -5.42 % 44.37 % 96.09 %
Updated On 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Oct 2023 31 Dec 2023
Profitability
DHR-PB TMO DHR IQV A IDXX
Gross Profit Margin TTM 58.45 % 40.3 % 59.41 % 29.7 % 50.71 % 60.14 %
Return on Assets TTM 5.33 % 6.33 % 5.35 % 5.39 % 11.44 % 25.84 %
Return on Equity TTM 8.42 % 13.48 % 8.04 % 22.79 % 20.87 % 63.66 %
Return on Capital Employed TTM 7.39 % 8.76 % 6.21 % 10.68 % 14.65 % 46.55 %
Net Income Per EBT TTM 83.98 % 90.86 % 99.88 % 94.99 % 93.45 % 79.58 %
EBT Per Ebit TTM 94.74 % 93.52 % 94.37 % 70.93 % 101.92 % 97.61 %
EBIT Per Revenue TTM 21.3 % 17.32 % 21.13 % 13.9 % 19.78 % 29.95 %
Cash Flow To Debt Ratio TTM 36.11 % 26.4 % 35.4 % 18.4 % 69.55 % 86.18 %
Receivables Turnover TTM 7.76 5.33 6.4 4.61 5.28 6.44
Payables Turnover TTM 6.49 - 5.21 3.23 7.05 12.64
Inventory Turnover TTM 4.12 4.86 3.21 - 3.25 3.8
Fixed Asset Turnover TTM 463.28 % 456.22 % 367.49 % 1979.04 % 429.94 % 449.53 %
Asset Turnover TTM 31.45 % 42.99 % 26.87 % 57.58 % 60.71 % 111.07 %
Operating Cash Flow Per Share TTM 9.27 24.47 8.74 13.39 6.47 11.09
Free Cash Flow Per Share TTM 7.39 20.85 6.92 10.03 5.25 9.59
Cash Per Share TTM 937.04 % 2309.69 % 321.85 % 920.97 % 570.31 % 478.28 %
Operating Cash Flow Sales Ratio TTM 26.52 % 22.08 % 30.55 % 16.05 % 28.77 % 24.73 %
Free Cash Flow Operating Cash Flow Ratio TTM 79.76 % 85.18 % 79.14 % 74.88 % 81.12 % 86.5 %
Cash Flow Coverage Ratios TTM 36.11 % 26.4 % 35.4 % 18.4 % 69.55 % 86.18 %
Price To Free Cash Flows Ratio TTM 35.66 29.1 38.77 23.91 26.05 48.69
Price To Operating Cash Flows Ratio TTM 29.55 24.81 31.34 17.9 21.22 42.37
Price Cash Flow Ratio TTM 29.55 24.81 31.34 17.9 21.22 42.37
Income Statement (TTM)
DHR-PB TMO DHR IQV A IDXX
Revenue $23.89B $42.86B $23.89B $15.01B $6.83B $3.66B
Gross Profit $14.03B $15.22B $14.03B $4.14B $3.47B $2.19B
Gross Profit Ratio 58.74% 35.52% 58.74% 27.56% 50.71% 59.82%
EBITDA $7.76B $10.72B $7.76B $3.21B $1.71B $1.1B
Net Income $4.76B $6B $4.76B $1.36B $1.24B $0.85B
EPS Diluted 6.38 15.45 6.38 7.29 4.19 10.06
Balance Sheet (MRQ)
DHR-PB TMO DHR IQV A IDXX
Long Term Debt $17.66B $31.31B $17.66B $12.96B $2.74B $0.62B
Total Liabilities $31B $51.88B $31B $20.57B $4.92B $1.78B
Total Equity $53.49B $46.84B $53.49B $6.11B $5.85B $1.48B
Total Investments $0.01B $-1.92B $0.01B $0.36B $0.16B $0.06B
Total Debt $19.54B $34.92B $19.54B $14.23B $2.74B $0.95B
Total Assets $84.49B $98.73B $84.49B $26.68B $10.76B $3.26B
Cash Flow Statement (TTM)
DHR-PB TMO DHR IQV A IDXX
Net Income $4.22B $6B $4.22B $1.36B $1.24B $0.85B
Inventory $0.19B $0.6B $0.19B $0B $-0.03B $-0.03B
Dividends Paid $-1.25B $-0.52B $-1.25B $0B $-0.27B $0B
Operating Cash Flow $7.16B $8.41B $7.16B $2.15B $1.77B $0.91B
Capital Expenditure $-1.38B $-1.48B $-1.38B $-0.65B $-0.3B $-0.13B
Related Stocks
Ticker Name Price
A Agilent Technologies, Inc. 137.32
ACRS Aclaris Therapeutics, Inc. 1.39
AKU Akumin Inc. 0.2887
APDN Applied DNA Sciences, Inc. 0.4101
AWH Aspira Women's Health Inc. 1.49
BDSX Biodesix, Inc. 1.72
BIAF bioAffinity Technologies, Inc. 2.71
BIAFW bioAffinity Technologies, Inc. 0.55
BIOC Biocept, Inc. 0.4349
BNGO Bionano Genomics, Inc. 0.627
BNR Burning Rock Biotech Limited 6.38
CDNA CareDx, Inc 19.01
CEMI Chembio Diagnostics, Inc. 0.455
CHEK Check-Cap Ltd. 2.01
CNTG Centogene N.V. 0.34
CO Global Cord Blood Corporation 2.9876
CRL Charles River Laboratories International, Inc. 233.47
CSTL Castle Biosciences, Inc. 21.06
DGX Quest Diagnostics Incorporated 145.59
DHR Danaher Corporation 273.91
Unlock